Alembic Pharma Secures US FDA Approval for Alcaftadine Ophthalmic Solution
Oct 4, 2024
Fda Equities
3D Systems (DDD) Stock Soars on FDA Clearance for Dental Solution
Sep 18, 2024
Cingulate Gears Up for Commercialization as FDA Nods to Marketing Approval Application for CTx-1301
Aug 14, 2024
Arcutis Biotherapeutics to Discuss ZORYVE® (Roflumilast Cream 0.15%) FDA Approval in Upcoming KOL Event
Jul 23, 2024
IceCure Medical's XSense Cryoablation System Granted FDA Approval
Jul 3, 2024
Extensive Delay in FDA Response to Abbott Nutrition Complaint Exposed by Audit
Jun 14, 2024
GENFIT Achieves FDA Approval Milestone with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Ipsen Achieves FDA Accelerated Approval for Iqirvo® as Innovative PPAR Treatment for Primary Biliary Cholangitis
Jun 11, 2024
FDA Approves Eisai's LEQEMBI® Maintenance Dosing Application for Early Alzheimer's Treatment
Jun 10, 2024
Biomea Fusion's Diabetes Drug BMF-219 Faces FDA Clinical Hold
Jun 6, 2024
Incannex Healthcare Announces Breakthrough in Opioid Use Disorder Treatment With Pre-IND Meeting Success
May 7, 2024
U.S. FDA Imposes New Regulations on Medical Test Manufacturers to Ensure Precision and Safety
Apr 29, 2024
FDA Grants Breakthrough Therapy Designation to MindMed's LSD Treatment for Anxiety
Mar 8, 2024
Liquidia Corporation Announces FDA Update on YUTREPIA™ Inhalation Powder NDA
Jan 25, 2024
Enhatch Receives FDA Clearance for TKA Instrumentation with AI Technology
Jan 25, 2024
Pasithea Therapeutics Kicks Off Phase 1 Trials for Advanced Cancer Treatment with PAS-004
Jan 3, 2024
The Call for Stricter FDA Oversight in Eyedrop Manufacturing
Dec 13, 2023